Shuichi Shimada
Overview
Explore the profile of Shuichi Shimada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sawamura S, Mijiddorj M, Kajihara I, Shimada S, Kanemaru H, Yamada-Kanazawa S, et al.
J Eur Acad Dermatol Venereol
. 2023 Feb;
37(6):e815-e817.
PMID: 36734603
No abstract available.
12.
Nakagawa T, Kawasaki Y, Sato S, Katayama H, Satake Y, Shimada S, et al.
Case Rep Oncol
. 2023 Jan;
15(3):1014-1020.
PMID: 36636673
In a rare case, free from systemic therapy, deferred cytoreductive nephrectomy was implemented in treating an advanced renal cell carcinoma with liver, lung, and splenic colon metastases. A 59-year-old man...
13.
Ishino T, Myangat T, Sawamura S, Kajihara I, Shimada S, Kanemaru H, et al.
J Dermatol
. 2023 Jan;
50(6):e189-e191.
PMID: 36628581
No abstract available.
14.
Nezu K, Kawasaki Y, Morimoto R, Ono Y, Omata K, Tezuka Y, et al.
Tohoku J Exp Med
. 2023 Jan;
259(3):229-236.
PMID: 36596503
Poor prognostic cardiac function is known among some patients with primary aldosteronism (PA). However, studies with echocardiograms on whether the normalization of aldosterone after laparoscopic adrenalectomy (LADX) improves myocardial hypertrophy...
15.
Sawamura S, Makino K, Ide M, Shimada S, Kajihara I, Makino T, et al.
Int J Mol Sci
. 2022 Jun;
23(12).
PMID: 35743254
Systemic sclerosis (SSc) is characterized by excessive collagen deposition in the skin and internal organs. Activated fibroblasts are the key effector cells for the overproduction of type I collagen, which...
16.
Chiba D, Kawasaki Y, Miyagi A, Katsumata Y, Satake Y, Shimada S, et al.
Tohoku J Exp Med
. 2022 Apr;
257(2):127-133.
PMID: 35418533
The present case study was conducted on a 74-year-old man who visited our department due to a left renal and retroperitoneal tumor on computed tomography (CT). The patient was diagnosed...
17.
Katsumata Y, Kawasaki Y, Tanaka K, Nakayama D, Katayama H, Shimada S, et al.
Case Rep Oncol
. 2021 Dec;
14(3):1522-1529.
PMID: 34899246
Here, we discuss the safety and management of adverse events associated with pembrolizumab plus axitinib combination therapy for metastatic renal cell carcinoma in patients on hemodialysis. A 76-year-old man was...
18.
Morozumi K, Kawasaki Y, Maekawa M, Takasaki S, Sato T, Shimada S, et al.
Cancer Sci
. 2021 Oct;
113(1):182-194.
PMID: 34710258
To improve treatment outcomes in real practice, useful biomarkers are desired when predicting postoperative recurrence for renal cell carcinoma (RCC). We collected data from patients who underwent definitive surgery for...
19.
Koyama J, Kawasaki Y, Kimura S, Sato T, Shimada S, Kawamorita N, et al.
Case Rep Oncol
. 2021 Feb;
14(1):8-12.
PMID: 33613235
Bladder tamponade due to hemorrhagic cystitis caused by BK virus in immunocompetent patients is familiar to urologists. BK virus is an important cause of nephropathy and graft loss in kidney...
20.
Sato T, Kawasaki Y, Maekawa M, Takasaki S, Morozumi K, Sato M, et al.
Metabolites
. 2020 Dec;
11(1).
PMID: 33374949
Metabolomics analysis possibly identifies new therapeutic targets in treatment resistance by measuring changes in metabolites accompanying cancer progression. We previously conducted a global metabolomics (G-Met) study of renal cell carcinoma...